메뉴 건너뛰기




Volumn 6, Issue 227, 2014, Pages

Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE INHIBITOR; L 870812; PLACEBO; RALTEGRAVIR; UNCLASSIFIED DRUG;

EID: 84897502032     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007701     Document Type: Article
Times cited : (39)

References (38)
  • 7
    • 77955673220 scopus 로고    scopus 로고
    • Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor
    • R. S. Veazey, T. J. Ketas, J. Dufour, T. Moroney-Rasmussen, L. C. Green, P. J. Klasse, J. P. Moore, Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor. J. Infect. Dis. 202, 739-744 (2010).
    • (2010) J. Infect. Dis. , vol.202 , pp. 739-744
    • Veazey, R.S.1    Ketas, T.J.2    Dufour, J.3    Moroney-Rasmussen, T.4    Green, L.C.5    Klasse, P.J.6    Moore, J.P.7
  • 11
    • 0032601403 scopus 로고    scopus 로고
    • HIV-1 integrase: Structural organization, conformational changes, and catalysis
    • E. Asante-Appiah, A. M. Skalka, HIV-1 integrase: Structural organization, conformational changes, and catalysis. Adv. Virus Res. 52, 351-369 (1999).
    • (1999) Adv. Virus Res. , vol.52 , pp. 351-369
    • Asante-Appiah, E.1    Skalka, A.M.2
  • 12
    • 0032601402 scopus 로고    scopus 로고
    • HIV integrase structure and function
    • D. Esposito, R. Craigie, HIV integrase structure and function. Adv. Virus Res. 52, 319-333 (1999).
    • (1999) Adv. Virus Res. , vol.52 , pp. 319-333
    • Esposito, D.1    Craigie, R.2
  • 13
    • 1842685176 scopus 로고    scopus 로고
    • The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors
    • E. Tramontano, L. Onidi, F. Esposito, R. Badas, P. La Colla, The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors. Biochem. Pharmacol. 67, 1751-1761 (2004).
    • (2004) Biochem. Pharmacol. , vol.67 , pp. 1751-1761
    • Tramontano, E.1    Onidi, L.2    Esposito, F.3    Badas, R.4    La Colla, P.5
  • 14
    • 79960690132 scopus 로고    scopus 로고
    • New first and second generation inhibitors of human immunodeficiency virus-1 integrase
    • A. Pendri, N. A. Meanwell, K. M. Peese, M. A. Walker, New first and second generation inhibitors of human immunodeficiency virus-1 integrase. Expert Opin. Ther. Pat. 21, 1173-1189 (2011).
    • (2011) Expert Opin. Ther. Pat. , vol.21 , pp. 1173-1189
    • Pendri, A.1    Meanwell, N.A.2    Peese, K.M.3    Walker, M.A.4
  • 17
    • 84870519207 scopus 로고    scopus 로고
    • Virological evidence supporting the use of raltegravir in HIV post-exposure prophylaxis regimens
    • M. D. Marsden, P. A. Krogstad, J. A. Zack, Virological evidence supporting the use of raltegravir in HIV post-exposure prophylaxis regimens. Antivir. Ther. 17, 1375-1379 (2012).
    • (2012) Antivir. Ther. , vol.17 , pp. 1375-1379
    • Marsden, M.D.1    Krogstad, P.A.2    Zack, J.A.3
  • 21
    • 79956206845 scopus 로고    scopus 로고
    • Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility
    • L. Livingston, E. Sweeney, J. Mitchell, W. Luo, K. Paul, N. Powell, R. Michael Hendry, J. McNicholl, E. Kersh, Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility. J. Med. Primatol. 40, 164-170 (2011).
    • (2011) J. Med. Primatol. , vol.40 , pp. 164-170
    • Livingston, L.1    Sweeney, E.2    Mitchell, J.3    Luo, W.4    Paul, K.5    Powell, N.6    Michael Hendry, R.7    McNicholl, J.8    Kersh, E.9
  • 22
    • 2142807626 scopus 로고    scopus 로고
    • Duke-UNC-Emory Acute HIV Consortium, Brief but efficient: Acute HIV infection and the sexual transmission of HIV
    • Quest Study
    • C. D. Pilcher, H. C. Tien, J. J. Eron Jr., P. L. Vernazza, S. Y. Leu, P. W. Stewart, L. E. Goh, M. S. Cohen; Quest Study; Duke-UNC-Emory Acute HIV Consortium, Brief but efficient: Acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 189, 1785-1792 (2004).
    • (2004) J. Infect. Dis. , vol.189 , pp. 1785-1792
    • Pilcher, C.D.1    Tien, H.C.2    Eron Jr., J.J.3    Vernazza, P.L.4    Leu, S.Y.5    Stewart, P.W.6    Goh, L.E.7    Cohen, M.S.8
  • 25
    • 84927600556 scopus 로고    scopus 로고
    • Impact of Depo-Provera and menstrual cycle on vaginal absorption of antiretroviral drugs from gels in pigtail macaques
    • Atlanta, GA, 3 to 6 March
    • C. Dobard, S. Sharma, Impact of Depo-Provera and menstrual cycle on vaginal absorption of antiretroviral drugs from gels in pigtail macaques, paper presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 3 to 6 March 2013.
    • (2013) The 20th Conference on Retroviruses and Opportunistic Infections
    • Dobard, C.1    Sharma, S.2
  • 26
    • 49849099241 scopus 로고    scopus 로고
    • Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
    • J. Atashili, C. Poole, P. M. Ndumbe, A. A. Adimora, J. S. Smith, Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies. AIDS 22, 1493-1501 (2008).
    • (2008) AIDS , vol.22 , pp. 1493-1501
    • Atashili, J.1    Poole, C.2    Ndumbe, P.M.3    Adimora, A.A.4    Smith, J.S.5
  • 27
    • 41949101138 scopus 로고    scopus 로고
    • Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239
    • A. M. Weiler, Q. Li, L. Duan, M. Kaizu, K. L. Weisgrau, T. C. Friedrich, M. R. Reynolds, A. T. Haase, E. G. Rakasz, Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239. J. Virol. 82, 4154-4158 (2008).
    • (2008) J. Virol. , vol.82 , pp. 4154-4158
    • Weiler, A.M.1    Li, Q.2    Duan, L.3    Kaizu, M.4    Weisgrau, K.L.5    Friedrich, T.C.6    Reynolds, M.R.7    Haase, A.T.8    Rakasz, E.G.9
  • 28
    • 84870670336 scopus 로고    scopus 로고
    • The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy
    • F. Christ, Z. Debyser, The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy. Virology 435, 102-109 (2013).
    • (2013) Virology , vol.435 , pp. 102-109
    • Christ, F.1    Debyser, Z.2
  • 29
  • 32
    • 84877123280 scopus 로고    scopus 로고
    • Next-generation integrase inhibitors: Where to after raltegravir?
    • S. L. Karmon, M. Markowitz, Next-generation integrase inhibitors: Where to after raltegravir? Drugs 73, 213-228 (2013).
    • (2013) Drugs , vol.73 , pp. 213-228
    • Karmon, S.L.1    Markowitz, M.2
  • 34
    • 19944428117 scopus 로고    scopus 로고
    • Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates
    • R. A. Otten, D. R. Adams, C. N. Kim, E. Jackson, J. K. Pullium, K. Lee, L. A. Grohskopf, M. Monsour, S. Butera, T. M. Folks, Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates. J. Infect. Dis. 191, 164-173 (2005).
    • (2005) J. Infect. Dis. , vol.191 , pp. 164-173
    • Otten, R.A.1    Adams, D.R.2    Kim, C.N.3    Jackson, E.4    Pullium, J.K.5    Lee, K.6    Grohskopf, L.A.7    Monsour, M.8    Butera, S.9    Folks, T.M.10
  • 38
    • 8044225290 scopus 로고    scopus 로고
    • Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines
    • I. M. Longini Jr., S. Datta, M. E. Halloran, Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13, 440-447 (1996).
    • (1996) J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. , vol.13 , pp. 440-447
    • Longini Jr., I.M.1    Datta, S.2    Halloran, M.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.